Clinical Research Directory
Browse clinical research sites, groups, and studies.
Oral Statins and Protection From Hearing Loss
Sponsor: Northwestern University
Summary
A small clinical trial for idiopathic sudden sensorineural hearing loss (ISSNHL). Will the addition of an oral statin to the standard treatment (oral methylprednesolone and the salvage therapy of intratympanic dexamethasone) improve the treatment outcome for patients with ISSNHL? This study will compare the two treatments and quantitatively evaluate hearing and speech discrimination and have the patients subjectively evaluate tinnitus.
Official title: Towards a Self-Administered Hearing Protection Regimen
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2023-02-09
Completion Date
2025-12-31
Last Updated
2024-12-05
Healthy Volunteers
No
Conditions
Interventions
Statin
Oral dose to be taken with methylprednisolone
methylprednisolone
oral dose, standard of care
dexamethasone
Drug for intratympanic administration
Placebo
Capsule the same as for statins but without statin
Locations (1)
Northwestern Memorial Hospital
Chicago, Illinois, United States